The groundbreaking success of Viagra, produced by copyright, undeniably revolutionized the management of erectile dysfunction , and fueled a massive boom in the healthcare sector. However, now, investing in firms reliant on aging blockbuster drugs like Viagra presents a intricate landscape. Generic competition is aggressive, considerably diminishin